Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Abbott Vascular
Beyond the checkbox: My views on compliance
By embedding compliance at the core of decision-making, medtech and life science companies will be ready to rise to future challenges When we think about the key trends shaping the healthcare sector, it quickly becomes clear that ethics and compliance have a central role to play in the future of our industry. Consider the risks arising from geopolitical change and the unique challenges of expanding in emerging markets. Think of how internal corporate environments are becoming more fast-paced.
In Transition: Early-Career Interventional Cardiologists
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Cath Lab Digest or HMP Global, their employees, and affiliates. Every year we graduate cardiology fellows and introduce them as new interventionalists into our community. It is our fervent hope and desire that they succeed and deliver great care to their patients.
Impact of Covid-19 on Angled Medical Guide Wire Market â?? Overview, Detail Analysis & Forecast to 2028
Latest Report on " Angled Medical Guide Wire Market size | Industry Segment by Applications ((Peripheral Artery Disease (PAD) , Cardiovascular Diseases ,By C
Unveiling expansion prospects in J-Shape Medical Guide Wire market outlook over 2022-2028
Latest Research Report on " J-Shape Medical Guide Wire Market size | Industry Segment by Applications ((Peripheral Artery Disease (PAD) , Cardiovascular Dise
Abbott Xience stent gains expanded CE mark
Abbott (NYSE:ABT) announced today that its Xience stent received CE mark approval for a shorter duration of dual anti-platelet therapy (DAPT). The European approval for the stent allows for the DAPT to go as short as 28 days, the shortest indication available in the world for patients with high bleeding risk (HBR), according to a news release.
Impact of Coronary Atherosclerosis on Bioresorbable Vascular Scaffold Resorption and Vessel Wall Integration
JACC: Basic to Translational Science Preclinical Research Yanping Cheng, Marco Ferrone, Qing Wang, Laura E.L. Perkins, Jennifer McGregor, Björn Redfors, Zhipeng Zhou, Richard Rapoza, Gerard B. Conditt, Aloke Finn, Renu Virmani, Grzegorz L. Kaluza and Juan F. Granada Author + information vol. 5 no. 6 619-629 History: Received December 20, 2019 Revision received April 2, 2020 Accepted April 6, 2020 Published online June 22, 2020.
In a potentially major change in the treatment of heart disease, hospitals will soon begin clearing some patient’s coronary arteries with biodegradable stents instead of metal devices that remain in the body forever.Earlier this week, the US Food and Drug Administration approved the use of Absorb, the first fully dissolvable stent for coronary artery disease, which kills 370,000 people in the US every year.The plastic stent opens clogged heart vessels, restoring blood flow.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Abbott
Contact Abbott, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack